Cargando…

Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans

Removal of the fucose residue from the N-glycans of the Fc portion of immunoglobulin G (IgG) results in a dramatic enhancement of antibody-dependent cellular cytotoxicity (ADCC) through improved affinity for Fcγ receptor IIIa (FcγRIIIa). Here, we present the 2.2-Å structure of the complex formed bet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mizushima, Tsunehiro, Yagi, Hirokazu, Takemoto, Emi, Shibata-Koyama, Mami, Isoda, Yuya, Iida, Shigeru, Masuda, Kazuhiro, Satoh, Mitsuo, Kato, Koichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2011
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258418/ https://www.ncbi.nlm.nih.gov/pubmed/22023369 http://dx.doi.org/10.1111/j.1365-2443.2011.01552.x

Ejemplares similares

Importance of the Side Chain at Position 296 of Antibody Fc in Interactions with FcγRIIIa and Other Fcγ Receptors
por: Isoda, Yuya, et al.
Publicado: (2015)

Conformational effects of N-glycan core fucosylation of immunoglobulin G Fc region on its interaction with Fcγ receptor IIIa
por: Sakae, Yoshitake, et al.
Publicado: (2017)

The N-linked oligosaccharide at FcγRIIIa Asn-45: an inhibitory element for high FcγRIIIa binding affinity to IgG glycoforms lacking core fucosylation
por: Shibata-Koyama, Mami, et al.
Publicado: (2009)

Backbone (1)H, (13)C, and (15)N resonance assignments of the Fc fragment of human immunoglobulin G glycoprotein
por: Yagi, Hirokazu, et al.
Publicado: (2014)

An Archaeal Homolog of Proteasome Assembly Factor Functions as a Proteasome Activator
por: Kumoi, Kentaro, et al.
Publicado: (2013)

Assessing the Heterogeneity of the Fc-Glycan of a Therapeutic Antibody Using an engineered FcγReceptor IIIa-Immobilized Column
por: Kiyoshi, Masato, et al.
Publicado: (2018)

Fc glycans of therapeutic antibodies as critical quality attributes
por: Reusch, Dietmar, et al.
Publicado: (2015)

Antitumor activities of a defucosylated anti-EpCAM monoclonal antibody in colorectal carcinoma xenograft models
por: Li, Guanjie, et al.
Publicado: (2023)

Improved secretion of glycoproteins using an N-glycan-restricted passport sequence tag recognized by cargo receptor
por: Yagi, Hirokazu, et al.
Publicado: (2020)

Augmentation of antitumour activity of defucosylated chimeric anti-CCR4 monoclonal antibody in SCID mouse model of adult T-cell leukaemia/lymphoma using G-CSF
por: Yano, Hiroki, et al.
Publicado: (2008)

Combination with a Defucosylated Anti-HM1.24 Monoclonal Antibody plus Lenalidomide Induces Marked ADCC against Myeloma Cells and Their Progenitors
por: Harada, Takeshi, et al.
Publicado: (2013)

Impact of Fc N-glycan sialylation on IgG structure
por: Zhang, Zhongqi, et al.
Publicado: (2019)

Structural Basis of Glycan Recognition of Rotavirus
por: Sun, Xiaoman, et al.
Publicado: (2021)

Defucosylated Mouse–Dog Chimeric Anti-EGFR Antibody Exerts Antitumor Activities in Mouse Xenograft Models of Canine Tumors
por: Li, Guanjie, et al.
Publicado: (2021)

Role for a Glycan Phosphoinositol Anchor in Fcγ Receptor Synergy
por: Green, Jennifer M., et al.
Publicado: (1997)

Dynamic Views of the Fc Region of Immunoglobulin G Provided by Experimental and Computational Observations
por: Yanaka, Saeko, et al.
Publicado: (2019)

Defucosylation of Tumor-Specific Humanized Anti-MUC1 Monoclonal Antibody Enhances NK Cell-Mediated Anti-Tumor Cell Cytotoxicity
por: Gong, Ying, et al.
Publicado: (2021)

Defucosylated mouse-dog chimeric anti-HER2 monoclonal antibody exerts antitumor activities in mouse xenograft models of canine tumors
por: Suzuki, Hiroyuki, et al.
Publicado: (2022)

Structural basis of laminin binding to the LARGE glycans on dystroglycan
por: Briggs, David C., et al.
Publicado: (2016)

Multi-level glyco-engineering techniques to generate IgG with defined Fc-glycans
por: Dekkers, Gillian, et al.
Publicado: (2016)

IgG1 Fc N-glycan galactosylation as a biomarker for immune activation
por: de Jong, Sanne E., et al.
Publicado: (2016)

First-in-human phase 1 study of IT1208, a defucosylated humanized anti-CD4 depleting antibody, in patients with advanced solid tumors
por: Shitara, Kohei, et al.
Publicado: (2019)

EndoS and EndoS2 hydrolyze Fc-glycans on therapeutic antibodies with different glycoform selectivity and can be used for rapid quantification of high-mannose glycans
por: Sjögren, Jonathan, et al.
Publicado: (2015)

Structural basis for Fc receptor recognition of immunoglobulin M
por: Chen, Qu, et al.
Publicado: (2023)

Structural basis for the recognition of complex-type N-glycans by Endoglycosidase S
por: Trastoy, Beatriz, et al.
Publicado: (2018)

Molecular basis for glycan recognition and reaction priming of eukaryotic oligosaccharyltransferase
por: Ramírez, Ana S., et al.
Publicado: (2022)

Improved Method for Drawing of a Glycan Map, and the First Page of Glycan Atlas, Which Is a Compilation of Glycan Maps for a Whole Organism
por: Natsuka, Shunji, et al.
Publicado: (2014)

Post-Synthetic Defucosylation of AGP by Aspergillus nidulans α-1,2-Fucosidase Expressed in Arabidopsis Apoplast Induces Compensatory Upregulation of α-1,2-Fucosyltransferases
por: Pogorelko, Gennady V., et al.
Publicado: (2016)

A Defucosylated Anti-EpCAM Monoclonal Antibody (EpMab-37-mG(2a)-f) Exerts Antitumor Activity in Xenograft Model
por: Asano, Teizo, et al.
Publicado: (2022)

A Humanized and Defucosylated Antibody against Podoplanin (humLpMab-23-f) Exerts Antitumor Activities in Human Lung Cancer and Glioblastoma Xenograft Models
por: Suzuki, Hiroyuki, et al.
Publicado: (2023)

Structural basis of redox-dependent substrate binding of protein disulfide isomerase
por: Yagi-Utsumi, Maho, et al.
Publicado: (2015)

Novel anticarcinoembryonic antigen antibody–drug conjugate has antitumor activity in the existence of soluble antigen
por: Shinmi, Daisuke, et al.
Publicado: (2017)

Human IgG/FcγR Interactions Are Modulated by Streptococcal IgG Glycan Hydrolysis
por: Allhorn, Maria, et al.
Publicado: (2008)

Significant Impact of Single N-Glycan Residues on the Biological Activity of Fc-based Antibody-like Fragments
por: Jez, Jakub, et al.
Publicado: (2012)

Effects of N-Glycan Composition on Structure and Dynamics of IgG1 Fc and Their Implications for Antibody Engineering
por: Lee, Hui Sun, et al.
Publicado: (2017)

Fc glycan sialylation of biotherapeutic monoclonal antibodies has limited impact on antibody‐dependent cellular cytotoxicity
por: Branstetter, Elaine, et al.
Publicado: (2021)

Oligomannose N-Glycans 3D Architecture and Its Response to the FcγRIIIa Structural Landscape
por: Fogarty, Carl A, et al.
Publicado: (2021)

Structural Basis and Evolution of Glycan Receptor Specificities within the Polyomavirus Family
por: Ströh, Luisa J., et al.
Publicado: (2020)

Structural basis for Glycan-receptor binding by mumps virus hemagglutinin-neuraminidase
por: Forgione, Rosa Ester, et al.
Publicado: (2020)

The Fab portion of immunoglobulin G contributes to its binding to Fcγ receptor III
por: Yogo, Rina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6jasoe7m7b2t42h0k2m4u1mgok